Bleeding Risk with Rivaroxaban, Enoxaparin, and Aspirin Following Total Joint Arthroplasty or Revision
intraoperative complications, venous thromboembolism, VTE, total joint arthroplasty, postoperative prophylaxis, bleeding risk
Analytical, Diagnostic and Therapeutic Techniques and Equipment | Internal Medicine | Medicine and Health Sciences | Pathological Conditions, Signs and Symptoms
Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is a potentially fatal byt preventable complication of orthopedic surgery. Following surgery, patients are routinely started on prophylactic oral or pareteral anticoagulation. Standard medicaions used in this setting include enoxaparin, low-dose ungractionated heparin, vitamin K antagonists, fondaparinux, apixaban, dabigatran, rivaroxaban, and aspirin. A major risk when using these medications is bleeding and must be considered when choosing among them.
Publisher or Conference
Rocky Mountain Healthcare Symposium
Watts P, Kopstein M, Harkness W, et al. Bleeding Risk with Rivaroxaban, Enoxaparin, and Asprin Following Total Joint Arthroplasty or Revision. Poster presented at: Rocky Mountain Healthcare Symposium; April 5, 2019; Aurora, CO.